pipette
ENEnglish

Distinct Progression Paths Underlie the Diversity of Pancreatic Papillary Cystic Neoplasms

C. Pignolet, L. Aguilera Munoz, L. Bourlet, T. Bourega, L. Gomes, D. Mendes, N. Theou-Anton, N. Colnot, M. Albuquerque, L. de Mestier, S. Dokmak, A. Couvelard, V. Rebours, R. Nicolle, J. Cros

PreprintUso en el mundo real

En palabras de los autores

Surgical decisions for intraductal papillary mucinous neoplasms (IPMNs), precursors of pancreatic cancer, depend on distinguishing low- from high-grade dysplasia, a distinction that molecular markers could refine. We microdissected 433 tumor regions from 135 patients and integrated transcriptomics, deep-learning histology, and KRAS/GNAS RNA-called variants. RNA programs and morphological motifs separated lesions by phenotype, intestinal versus others, rather than by dysplasia grade. Along gastric IPMN trajectories, low-grade lesions recapitulated the pit-chief polarity of normal gastric glands, whereas high-grade lesions were indistinguishable from pancreatobiliary lesions in morphology, RNA programs, and driver mutations. Intestinal IPMNs arose through two routes: a canonical GNAS-associated pathway and a KRAS-associated shift from low-grade gastric features, with lesions sharing driver mutations retaining common programs across phenotypes. Resolving these phenotypic trajectories clarified distinct progression paths and enabled phenotype-specific prediction of high-grade dysplasia in mucus aspirated from 94 resected lesions. These findings support a promising fluid-based assessment of IPMN status.

Resultado principalEl resumen no menciona limitaciones.

Apareció: jueves, 8 de octubre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.10.06.757128